Literature DB >> 1281980

A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.

J Ghiso1, A Rostagno, J E Gardella, L Liem, P D Gorevic, B Frangione.   

Abstract

Amyloid beta (A beta), the major constituent of the fibrils composing senile plaques and vascular amyloid deposits in Alzheimer's disease (AD) and related disorders, is a 39-42-residue self-aggregating degradation peptide of a larger multidomain membrane glycoprotein designated amyloid precursor protein (APP). An array of biological functions has been assigned to different APP domains, including growth regulation, neurotoxicity, inhibitory activity of serine proteinases and promotion of cell-cell and cell-matrix interactions. A beta is generated through an as-yet-unknown catabolic pathway that by-passes or inhibits the cleavage of APP within the A beta sequence. We have identified a 16 kDa intermediate APP C-terminal fragment containing A beta in leptomeningeal vessels of aged normal individuals and AD patients by means of its immunoreactivity with a panel of four different anti-(APP C-terminal) antibodies, indicating a different pathway of APP processing. Previous studies have indicated that the APP C-terminal domain is the most likely to be involved in cell-matrix interactions. A 109-amino-acid construct C109 with a sequence analogous to the C-terminal of APP (positions 587-695 of APP695), similar in length and immunoreactivity to the 16 kDa fragment, was found to promote cell adhesion. By use of synthetic peptides, this activity was initially located to the extracellular 28 residues of A beta. Inhibition studies demonstrated that the sequence RHDS (amino acids 5-8 of A beta, corresponding to residues 601-604 of APP695 was responsible for the adhesion-promoting activity. The interaction is dependent on bivalent cations and can be blocked either by the tetrapeptides RHDS and RGDS or by an anti-(beta 1 integrin) antibody. Thus, through integrin-like surface receptors, APP or its derivative proteolytic fragments containing the sequence RHDS may modulate cell-cell or cell-matrix interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281980      PMCID: PMC1131993          DOI: 10.1042/bj2881053

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  61 in total

1.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

2.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

Authors:  B A Yankner; L R Dawes; S Fisher; L Villa-Komaroff; M L Oster-Granite; R L Neve
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

3.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

4.  Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor.

Authors:  W E Van Nostrand; S L Wagner; M Suzuki; B H Choi; J S Farrow; J W Geddes; C W Cotman; D D Cunningham
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

5.  Decreased adhesiveness of Alzheimer's disease fibroblasts: is amyloid beta-protein precursor involved?

Authors:  K Uéda; G Cole; M Sundsmo; R Katzman; T Saitoh
Journal:  Ann Neurol       Date:  1989-03       Impact factor: 10.422

6.  In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein.

Authors:  E M Castaño; J Ghiso; F Prelli; P D Gorevic; A Migheli; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

7.  Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern.

Authors:  P D Gorevic; E M Castano; R Sarma; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1987-09-15       Impact factor: 3.575

8.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Fibronectin receptors of mononuclear phagocytes: binding characteristics and biochemical isolation.

Authors:  A Garcia-Pardo; O C Ferreira; J Valinsky; C Bianco
Journal:  Exp Cell Res       Date:  1989-04       Impact factor: 3.905

10.  Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact.

Authors:  B D Shivers; C Hilbich; G Multhaup; M Salbaum; K Beyreuther; P H Seeburg
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

View more
  28 in total

1.  A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

Authors:  Maria E Bamberger; Meera E Harris; Douglas R McDonald; Jens Husemann; Gary E Landreth
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

2.  New tricks from an old dog: Another synaptotoxic fragment from APP.

Authors:  Sheue-Houy Tyan; Edward H Koo
Journal:  Cell Res       Date:  2015-10-27       Impact factor: 25.617

3.  Complex pharmacokinetics of a humanized antibody against human amyloid beta peptide, anti-abeta Ab2, in nonclinical species.

Authors:  Yulia Vugmeyster; Pam Szklut; David Wensel; John Ross; Xin Xu; Michel Awwad; Davinder Gill; Lioudmila Tchistiakov; Garvin Warner
Journal:  Pharm Res       Date:  2011-03-18       Impact factor: 4.200

4.  Protease nexin-2/amyloid beta-protein precursor limits cerebral thrombosis.

Authors:  Feng Xu; Judianne Davis; Jianting Miao; Mary Lou Previti; Galina Romanov; Kelly Ziegler; William E Van Nostrand
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

Review 5.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

6.  High-level expression and in vitro mutagenesis of a fibrillogenic 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein.

Authors:  J E Gardella; G A Gorgone; L Candela; J Ghiso; E M Castaño; B Frangione; P D Gorevic
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

Review 7.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

8.  The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.

Authors:  J Ghiso; E Matsubara; A Koudinov; N H Choi-Miura; M Tomita; T Wisniewski; B Frangione
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

Review 9.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

10.  Systematic evaluation of candidate ligands regulating ectodomain shedding of amyloid precursor protein.

Authors:  Heather C Rice; Tracy L Young-Pearse; Dennis J Selkoe
Journal:  Biochemistry       Date:  2013-05-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.